Grace Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Grace Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2020 to Q1 2024.
  • Grace Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $0 -$463K -100% Mar 31, 2024 10-K 2024-06-21
Q4 2023 $23K -$464K -95.3% Dec 31, 2023 10-Q 2024-02-12
Q3 2023 $47K -$463K -90.8% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $71K -$748K -91.3% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $463K +$148K +47% Mar 31, 2023 10-K 2024-06-21
Q4 2022 $487K +$465K +2114% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 $510K +$467K +1086% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $819K +$753K +1141% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $315K +$229K +266% Mar 31, 2022 10-K 2023-06-23
Q4 2021 $22K -$83K -79% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 $43K -$76K -63.9% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $66K -$69K -51.1% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $86K -$61K -41.5% Mar 31, 2021 10-K 2022-06-21
Q4 2020 $105K Dec 31, 2020 10-Q 2021-02-09
Q3 2020 $119K Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $135K Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $147K Mar 31, 2020 10-K 2021-06-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.